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Abstract
The clinical relevance of recovering Aspergillus species in
intensive care unit patients is unknown. Diagnosis of invasive
pulmonary aspergillosis is extremely difficult because there are no
specific tests sensitive enough to detect it. The rapidly fatal
prognosis of this infection without treatment justifies early
antifungal therapy. A clinical algorithm may aid clinicians to manage
critically ill patients from whose respiratory specimens Aspergillus
spp. have been isolated. This new tool needs to be validated in a
large cohort of patients before it can be recommended.
The management of critically ill patients with a suspected
invasive fungal infection based on predefined clinical and
microbiological criteria or the punctuation of a score may be a
valid approach when the definitive diagnosis is feasible only
in a small proportion of patients. This is what Vandewoude
and colleagues propose with their retrospective analysis of all
patients who had Aspergillus spp. isolated from their
respiratory samples [1].
Fungal infections have increased in intensive care units (ICUs)
over the past decades. Although less common than candidiasis,
aspergillosis is more likely to result in a life-threatening
infection. The most important host defences against
Aspergillus are neutrophils and alveolar macrophages. Thus,
neutropenic patients, and those who receive long-lasting
corticosteroid treatments, are at high risk for invasive
aspergillosis [2].
Exposure to Aspergillus spp. is a common occurrence. This
organism grows on a wide variety of organic material and the
conidia are easily aerosolised. Although exposure is universal,
invasive infection occurs almost entirely in immuno-
suppressed individuals. Outbreaks have been described in
bone marrow transplantation, solid organ transplant
recipients and leukaemia patients in association with hospital
construction and/or ventilation system contamination with
Aspergillus. Moreover, hospital water is a frequently over-
looked source of nosocomial aspergillosis [3].
Critically ill patients can also develop invasive aspergillosis
independent of classic risk factors [4,5]. Indeed, multiple
organ failure and prolonged stays in the ICU are associated
with a complex decrease in immune functions, deactivation of
macrophages and altered cellular response [6].
Diagnosis of invasive aspergillosis with confidence is
extremely difficult in ICU patients. Isolation of Aspergillus spp.
may correspond to a mere colonisation. Confirmation of the
diagnosis obliges the demonstration of histopathological
evidence of Aspergillus. This is usually not feasible given the
special circumstances of critically ill ventilated patients.
Likewise, screening the blood for galactomannan may be very
valuable in neutropenic patients but its usefulness in ICU
patients is limited. Before new antifungal agents were
available, mortality of critically ill patients with invasive
aspergillosis was nearly 100% [7,8]. Currently, the thera-
peutic armoury has significantly improved with the introduc-
tion of new azoles (i.e., voriconazole) and the echinocandins
(i.e., caspofungin), a new class of drugs with a novel target
[9,10].
Many problems contribute to the lack of confident and timely
diagnosis of invasive aspergillosis in critically ill patients. On
one hand, the early administration of antifungal agents may be
life-saving, but clinicians must also bear in mind the problems
and costs associated with needless treatments derived from
the overinterpretation of the potential clinical significance of
isolates of Aspergillus spp. in respiratory samples. How can
we attempt to solve this dilemma?
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Van de Woude et al. [1] propose a clinical algorithm based
on the criteria defined by an international conference on the
diagnosis of aspergillosis in immunocompromised patients
[11]. With this approach, approximately 50% of the patients
were diagnosed with invasive aspergillosis and in the other
50% the isolation was considered colonization [1]. These
diagnoses were confirmed in all cases in which histology was
obtained. Unfortunately, histology was available only in a
small proportion of patients (one-fourth of patients with
presumed diagnosis of infection and one-tenth of the patients
with the diagnosis of colonization). At first glance, these
results seem very hopeful, although positive and negative
predictive values cannot be calculated with these figures.
The diagnostic accuracy of this algorithm can be improved.
Many authors have documented that invasive aspergillosis can
occur in certain types of ‘non-immunocompromised’ critically
ill patients. Three high risk groups stand out for invasive
aspergillosis: chronic obstructive pulmonary disease [4,5],
prolonged multiple dysfunction syndrome in the situation of
immunoparalysis [12], and severe hepatic failure [4]. These
underlying conditions are not included in the proposed criteria
and they should be added to the list. This may avoid the
misclassification of these high risk patients if semiquantitative
culture of bronchoalveolar lavage was not positive [13], a
criterion not universally accepted. Moreover, a high resolution
CT scan is nowadays mandatory and a normal portable chest
X-ray may lead to an erroneous classification [2].
The significance of a positive respiratory culture for
Aspergillus spp. in a non-immunodepressed patient causes
the clinician great uncertainty and doubt. Nowadays, the
isolation of Aspergillus spp. in a critically ill patient is not an
exceptional curiosity. Definitions proposed by the European
Organisation for the Research and Treatment of Cancer were
not designed to guide clinical practice [11]. Critical care
physicians need a helpful instrument to decide in which
circumstances antifungal therapy should be initiated early,
given the high mortality of this infection but the availability of
new and active agents. Obviously, this and other strategies
need to be validated in large cohorts of critically ill patients
before they can be recommended [13,14]. This is an urgent
task because we do not expect to have at our disposal a
precise microbiological test in the near future. Therefore,
ready, steady, go!
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